IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression.
about
SUMO1 modification of NF-kappaB2/p100 is essential for stimuli-induced p100 phosphorylation and processingA NIK-IKKα module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1Dysregulation of ubiquitin ligases in cancerA cell cycle regulatory network controlling NF-kappaB subunit activity and functionAlternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation.EZH2 depletion blocks the proliferation of colon cancer cells.Constitutive non-canonical NFkappaB signaling in pancreatic cancer cellsCutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2.Cyclin-dependent kinase 6 phosphorylates NF-κB P65 at serine 536 and contributes to the regulation of inflammatory gene expression.Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicityTranslational repression of MCL-1 couples stress-induced eIF2 alpha phosphorylation to mitochondrial apoptosis initiation.Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma.AMPKα2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells.Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation.Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancerFoxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylationNF-kappa B as a target for cancer therapy.The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway.Apoptotic pathways in pancreatic ductal adenocarcinomaIRF6 in development and disease: a mediator of quiescence and differentiation.Cytoplasmic TRADD confers a worse prognosis in glioblastomaNuclear factor κB2 p52 protein has a role in antiviral immunity through IκB kinase epsilon-dependent induction of Sp1 protein and interleukin 15Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells.PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancerAcetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma.Roles of the Skp2/p27 axis in the progression of chronic nephropathy.NF-κB and the cell cycle.LXR activation causes G1/S arrest through inhibiting SKP2 expression in MIN6 pancreatic beta cells.Sumoylation of HDAC2 promotes NF-κB-dependent gene expression.c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells.NFκB regulates expression of Polo-like kinase 4.Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK.Fungal-induced cell cycle impairment, chromosome instability and apoptosis via differential activation of NF-κB.Up-regulation of Cks1 and Skp2 with TNFα/NF-κB signaling in chronic progressive nephropathy.A proteomic investigation of B lymphocytes in an autistic family: a pilot study of exposure to natural rubber latex (NRL) may lead to autism.Cross talk between stimulated NF-kappaB and the tumor suppressor p53.Retinoic acid-induced nNOS expression depends on a novel PI3K/Akt/DAX1 pathway in human TGW-nu-I neuroblastoma cells.RelB is differentially regulated by IkappaB Kinase-alpha in B cells and mouse lung by cigarette smoke.IkappaBbeta is an essential co-activator for LPS-induced IL-1beta transcription in vivo.
P2860
Q24312155-E2D8BE4C-B6F5-4FD4-9626-B393612DDA50Q24338768-519AC892-23F7-4B6A-BB5E-C0932CEF0A4DQ28086796-CA8D0762-8CDC-4FB6-85D0-A5A8D4D496E6Q28116296-97E6D9D3-5B55-49C9-869C-48AB12E94335Q33859710-CC0E6B60-60C3-4941-AAB5-3525BEA7AB01Q33963796-13255669-2C25-4003-8837-96BEBC5D6DFBQ34021737-BD8C576D-90DB-4B10-8101-E080E2BBEA74Q34081681-3706F905-3DC2-4203-AC44-B8B000495F2BQ34540259-889008B1-6C6E-4FF6-AD5C-3E992B6099C1Q34542594-4DFC3CDD-6D9C-4361-8D43-FB53B274B4BEQ34635166-8F700830-A6AE-41A1-AD79-CE442FA656BDQ35571884-103B1C0D-38C7-45AE-BD94-84F6358A3B74Q35606335-49B6F518-070F-497D-AA79-FBBD083AFD38Q36273261-82CE51D3-E8F2-4230-A49C-CA1E9E840BC2Q36481359-5144AF8B-A1D5-4B9E-A683-4904D704DCC5Q36508271-7D6D5012-F501-4B2A-8312-DCDC7DC3345DQ36585524-6FFC7E22-4DB0-448C-ADE7-7F2FE82C062DQ36709532-00F24BF8-00D8-4CBA-B2BE-BC57471FF0AEQ36835317-4596034E-BC5C-4E71-AC65-6CDC638B5D04Q36835642-5B951B50-0074-4E0E-A6E0-D3446E55D77DQ36968117-C5473C22-B572-4058-ACBB-EF7D2A5751F9Q37061012-51D04164-9253-49B3-B0DC-2412684C47ACQ37132045-8CEB31A3-FB05-48C0-A9B1-1D76A92F8ADCQ37382511-CB7CE5F9-6FBF-4274-A314-12AE73E10276Q37640708-E7B59B65-1971-400F-8AF9-091A02DDD502Q37832684-23CDA7D6-047C-4571-B0BC-83783F525464Q38068794-0DB0DD1B-ACF6-4242-BC4F-F0A0F2659F7AQ38180760-5EB1218E-81A7-44D7-AE8C-1ED26097988CQ38778800-CE5D9B0A-AE27-40F7-9115-8A3B05303294Q38907048-26D1ABAC-2100-4E9F-83D9-01A2A0AE23A9Q38949421-53104529-D13B-4ADB-9231-1E91DABAC6ECQ39105565-8304FB23-59D1-44C6-BDDA-2C30FEC99E1FQ39297691-328E70D3-B565-45C6-A5FD-B84BEBBB87EEQ39384062-54F5B286-D085-4AC7-9CFF-9C8630CB9A8DQ39454841-CB75FF8D-416F-419C-A6DE-7F8AAA904460Q39642419-7ADD4413-6B33-47D4-B347-CA84C66CF43EQ39734014-060A7285-E637-40D6-AE4D-43157B7973A6Q39804308-2EDFCF5D-10D9-4736-BD40-D5E161FCEC5BQ39952776-64B67CC8-2FDA-4645-8031-362FF12039F7Q41676808-F3331C6C-9838-4154-8762-B9B02123A9CD
P2860
IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
IKKalpha controls p52/RelB at ...... te G1- to S-phase progression.
@en
type
label
IKKalpha controls p52/RelB at ...... te G1- to S-phase progression.
@en
prefLabel
IKKalpha controls p52/RelB at ...... te G1- to S-phase progression.
@en
P2093
P2860
P356
P1433
P1476
IKKalpha controls p52/RelB at ...... ate G1- to S-phase progression
@en
P2093
Dieter Saur
Günter Schneider
Jens T Siveke
Roland M Schmid
P2860
P304
P356
10.1038/SJ.EMBOJ.7601259
P407
P577
2006-08-10T00:00:00Z